Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in "Immune Desert" NSCLC.

Ioannis S PaterasAthanasios KotsakisMargaritis AvgerisEvangelia BaliouPanagiotis KouroupakisEleni PatseaVassilis GeorgouliasJeanne Menez-JametJean-Pierre KinetKostas Kosmatopoulos

Published in: Cancers (2021)

These results support the hypothesis that Vx-001 may be efficient in patients with non-immunogenic/cold but not with immunogenic/hot tumors.

Keyphrases

papillary thyroid
small cell lung cancer
squamous cell
advanced non small cell lung cancer
brain metastases